cbdMD, Inc. (AMEX: YCBD) is Growing Revenues with Licensing Deals and New CBD Products

cbdMD, Inc. (AMEX: YCBD) is Growing Revenues with Licensing Deals and New CBD Products

Update 01/21/21 Note* Following a name and symbol change Level Brands is now cbdMD, Inc. (AMEX: YCBD)

Level Brands, Inc. (NYSE: LEVB) is an innovative marketing and licensing company that provides bold, unconventional, and socially responsible branding for leading businesses.

On October 2nd, the company announced the closing of its previously announced underwritten public offering for total gross proceeds of $6,899,998. The Company sold an aggregate of 1,971,428 shares of its common stock at a purchase price of $3.50 per share in this offering. The Company intends to use the net proceeds from the offering for brand development and expansion, acquisitions and general working capital. This financial closure brings significant financial flexibility and enhances the overall liquidity for LEVB.

On the financial performance front, the company reported excellent numbers in its Q3 results on August 14th, 2018. The Company’ performance reflected the strong foundation that Level has laid. By leveraging the expertise and talent of the Kathy Ireland® Worldwide executive team, Level Brands has a distinct competitive advantage in securing strategic licenses and joint venture partnerships for its clients, positively impacting its ability to continue to grow the portfolio of brands it manages and represent. Moreover, the company also continues to be at the forefront of the CBD industry. On September 21st, the company announced the online launch of five new cannabidiol (CBD) products under the Kathy ireland® Health & Wellness brand.


Highlights of quarterly performance:


  • Total Net Sales up 105% for the nine months ended June 30 compared to same period 2017
  • Gross Profit as a Percentage of Net Sales was 65.4% in Q3 and 73.3% for the nine months ended June 30
  • Net Income of $206,074 in Q3 and $477,542 for the nine months ended June 30 vs. losses in year-ago periods


Additionally, it’s important to note the royalty components of many of the licensing deals signed this year have yet to be generated and therefore are not reflected in the aforesaid reported numbers. As LEVB execute on these agreements and continue to sign more clients, its pipeline of potential future royalties grows exponentially, and with no inventory and tight cost controls, it believes that the high margin operation should see much of this reach its bottom line, which should lead to significant shareholder value creation.

Industry Potential: The management believes that the CBD industry will see enormous growth over the next decade on a global scale. Recently, the Brightfield Group reported that the global market for CBD could top $22 billion in the next four years. If passed, the 2018 Farm Bill which includes the Hemp Farming Act of 2018, will remove hemp as a designated controlled substance thereby legalizing the crop under federal law, which will allow CBD to be legally sold in all 50 states. The passage of the 2018 Farm Bill, which would replace the 2017 Farm Bill which expires on September 30, 2018, would be a significant positive development for the industry.

Analyst tracking the stock are excited for what the future holds and believe that LEVB is ideally positioned to capitalize on multi-billion-dollar opportunities in millennial men’s lifestyle markets and the health and wellness arena for women and their families at every age.

About the Company: Level Brands is an innovative marketing and licensing company that provides bold, unconventional, and socially responsible branding for leading businesses. The focus of LEVB is licensing and corporate brand management for consumer products, including art, beauty, fashion, the beverage space, health and wellness, and entertainment. License brand marketing is at the core of the Level Brands businesses: Kathy ireland® Health & Wellness; Ireland Men One (I’M1), a men’s lifestyle brand established to capitalize on potentially lucrative licensing and co-branding opportunities with brands focused on millennials; Encore Endeavor One (EE1), a provider of corporate brand-management services and producer of experiential entertainment events and products across multiple platforms.

Business Model:

  • LEVB provide instant brand recognition, creating bold, socially-responsible branding for leading businesses through its Kathy ireland®Health & Wellness and Ireland Men One (I’M1) brands.
  • The company’ brand management business helps companies develop strategies that create brand awareness, access new markets, and sell products.
  • Consumer-products focused, targeting health & wellness, fashion, beauty, and entertainment.
  • LEVB is building a strong and consistent (recurring) royalty stream from its services and product sales.

Recent performance highlights:

  • Signed 10-year, multimillion-dollar cannabidiol (CBD) products license deal with Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6A.F)
  • Isodiol launched first five new CBD kathy ireland® Health & Wellness branded products as part of an Isodiol license agreement
  • Brought together Isodiol and SG Blocks, another Level Brands’ client, to roll-out KURE Corp.’s specialty Vape Pod™ stores
  • Signed five-year licensing agreement with Gravocore fitness system, launched in 2017 in an exclusive partnership with Amazon
  • Partnered with BMG, a multinational record label, and the world’s fourth-largest music-publishing company, to launch a new record label with three project agreements
  • Signed seven-year licensing agreement with Boston Therapeutics to market its diabetes supplement, Sugardown®; deal generates $850,000 in upfront fees plus royalties on gross sales
  • Party to a three-year licensing agreement with Lamps Plus to showcase the artwork of world-renowned neo-pop artist Romero Britto
  • Damiva launched 100% natural women’s personal care products into health food stores with Kathy ireland® Worldwide
  • Signed a five-year licensing deal with Dynasty Group USA, one of the largest American-owned manufacturers of high-quality, cruelty-free cosmetic brushes
  • Signed a licensing agreement with Society Hill Spirits for new Beauty & Pin-Ups vodka line
    Opened corporate office and design studio in Los Angeles


LEVB has a fiscal year end of September 30

  • Revenue – Total net sales increased 79% and 105% to $3.2 million and $7.0 million, respectively, for the three and nine-month periods ended June 30, 2018, from the comparable periods in fiscal 2017.
  • Gross profit – as a percentage of net sales was 65.4% for the three months ended June 30, 2018. For the nine-month period, gross profit as a percentage of net sales was 73.3%.
  • Net income – attributable to common shareholders improved 197.8% to $206,074 in the three months ended June 30, 2018, from the comparable period in fiscal 2017. For the nine-month period, net income improved 134.1% to $477,542, up from a loss of $1.4 million in the prior-year comparable period.

Key risk factors and potential stock drivers:

  • Analysts expect that revenue and earnings will be the critical catalyst for Canopy Growth over the near to medium term and the company is expected to grow significantly especially as a result of their operations within Canada which is a month from legalizing marijuana federally.
  • Notwithstanding CGC’ unique and differentiating factors, the company is still exposed to risk related to competition and peer pressure. There are other highly diversified cannabis companies in the industry. Additionally, there’s a cannabis ETF that recently launched for even more diversification.
  • Company’ ability to grow revenue while significantly improving its profitability will continue to remain a critical price sensitivity for the company
  • The company continues to face significant regulatory risks and uncertainty, while at the same time additional states legalize cannabis.
  • The cannabis industry is, in many respects, still in the early stages of its development and only time would differentiate between real winners and laggards. As far as choosing an option with a relative advantage is concerned, CGC is preferred choice with upside potential.


Stock Chart:

LEVB stock chart


  • On Monday, October 15th, 2018, LEVB was at $4.81, on volume of 305K shares exchanging hands. Market capitalization is $50.376 million. The current RSI is 52.71
  • In the past 52 weeks, shares of LEVB have traded as low as $2.74 and as high as $24.91
  • At $4.81, shares of LEVB are trading above its 50-day moving average (MA) at $3.88 and above its 200-day moving average (MA) at $4.19
  • The present support and resistance levels for the stock are at $4.50 & $5.32 respectively.


Traders News Source Recent Reports

Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.
Traders News Source has not been compensated for this report by anyone and the opinions if any are that of the author Vikas Agrawal, CFA. Author’s Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I, wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in the article.
This web site, published by TNS LLC, and is an investment newsletter that is built on the premise of assisting individual investors in learning about investing. Our goal as publishers of financial information is to provide research and analysis of investments to our subscribers. TNS LLC does not give buy or sell recommendations. We do purchase distribution rights from analyst, financial writers and bloggers for a fee that may be licensed to issue price targets and recommendations. Furthermore, we encourage you to speak to a licensed professional prior to making an investment in any type of publicly traded security.
We do sell advertising to other companies including brokerage firms, web sites, publicly traded issuers, investor relations firms, and investment publications, among others. TNS LLC makes no warranty as to the policies of these organizations, and in no way endorses their offers, services, or the content of their advertisements.
When an advertiser is a publicly traded company or a third party acting on behalf of a public company, we fully disclose all compensation in the email advertisement. Such disclosure is included in a disclosure statement in each of the advertisements sent via email.
17B Disclosure
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
PLEASE NOTE WELL: TNS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operator’s owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.
TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur.
Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.